CHEOY Company Profile and Key Details

Average 10-day trading volume of 15.06 thousand shares is below the 3-month average of 37.56 thousand, indicating normal recent market interest.

Cochlear Limited (OTC:CHEOY) closed at $48.15 USD, losing -$0.22 (-0.45%) from the previous close of $48.37. The stock is currently mid-range between its 52-week high and low $31.82 and $102.63. With a market capitalization of about $6.30 billion, Cochlear Limited is classified as a mid-cap and shows lower-than-market volatility (beta ~0.26). Key stats such as the average daily volume over the past year has been around 38.46 thousand shares, volume is running light vs its 52-week average. Headquartered in Sydney, NSW, Cochlear Limited operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Diggory William Howitt, the company employs approximately 5,400 people and listed since April 05, 2010. Cochlear Limited is a global healthcare company specializing in advanced auditory solutions.

Cochlear Limited last paid a dividend of 1.45 per share, this equals a trailing yield of roughly inf%. Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $36.61. This means the shares are trading above this model’s fair value.

Cochlear Limited trades at a P/E ratio of 62.08, slightly above the S&P 500 average, with a price-to-sales ratio of 3.85 and a price-to-book ratio of 5.15 trading at moderately above to book value. The P/FCF stands at 28.47, also above market averages.

Valuation shows Cochlear Limited trading at a premium to the broader market with a P/E of 62.08.

Our AI price prediction model suggests that Cochlear Limited stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.